Journal of Infectious Diseases and Medical Microbiology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Short Communication - Journal of Infectious Diseases and Medical Microbiology (2025) Volume 9, Issue 3

Nosocomial Pathogens: The Silent Threat in Healthcare Settings

Julia Paludan*

Institute for Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Austria

*Corresponding Author:
Julia Paludan
Institute for Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Denmark
E-mail: julia.paludan@meduniwien.ac.at

Received: : 03-May-2025, Manuscript No. AAJIDMM- 25- 165787; Editor assigned: 05-May-2025, PreQC No. AAJIDMM- 25-165787 (PQ); Reviewed: 11-May-2025, QC No. AAJIDMM- 25-165787; Revised:25-May-2025, Manuscript No. AAJIDMM- 25-165787 (R); Published: 31-May-2025, DOI:10.35841/10.35841/aajidmm-9.3.270

Citation: Citation: Paludan J. Nosocomial Pathogens: The Silent Threat in Healthcare Settings.2025; 9(3):268

Abstract

  

Introduction

Nosocomial infections, also known as hospital-acquired infections (HAIs), are infections that patients acquire while receiving treatment for other conditions within a healthcare setting. These infections are caused by various microorganisms, collectively referred to as nosocomial pathogens, and can significantly impact patient health, increase healthcare costs, and lead to longer hospital stays. Nosocomial pathogens are a major concern in both developed and developing countries due to the widespread use of invasive medical procedures, antibiotic resistance, and the crowded nature of hospitals. This article explores the types of nosocomial pathogens, the factors contributing to their spread, and the measures taken to prevent and control these infections in healthcare environments. [

Nosocomial infections are acquired during a patient’s stay in a hospital or healthcare facility. They typically develop 48 hours or more after admission, or within 30 days of receiving care, and are not present or incubating at the time of admission. The pathogens responsible for these infections can be transmitted directly between patients or indirectly via contaminated equipment, surfaces, or healthcare workers' hands. The types of nosocomial infections vary, but they most commonly affect the urinary tract, respiratory system, surgical wounds, bloodstream, and gastrointestinal tract. These infections can range from mild and self-limiting to severe and life-threatening, with certain patients, such as those with weakened immune systems, being more susceptible.[

Bacterial infections are the most common cause of nosocomial infections. MRSA is notorious for causing surgical wound infections, bloodstream infections, and pneumonia. It is resistant to many antibiotics, making treatment more difficult. This bacterium causes antibiotic-associated diarrhoea and colitis, typically after the use of broad-spectrum antibiotics. C. difficile can produce spores that survive in the hospital environment, making it particularly challenging to control. Often associated with urinary tract infections (UTIs), E. coli can also lead to bloodstream infections and surgical site infections, particularly in immunocompromised patients. This opportunistic pathogen is found in hospital environments and can cause infections in patients with weakened immune systems, particularly those with burns, respiratory illnesses, or invasive devices like catheters and ventilators. [5, 6].

Several viruses are also responsible for nosocomial infections, particularly among patients in intensive care or those with weakened immune defences. Known for causing gastroenteritis outbreaks, norovirus can spread quickly in healthcare settings, particularly in long-term care facilities and hospitals with high patient turnover. The flu virus can spread rapidly in healthcare settings, particularly during seasonal outbreaks. It can lead to respiratory infections and complicate the conditions of patients with chronic illnesses. HSV can cause viral infections of the skin, eyes, and mucous membranes, and it can be particularly harmful in immunocompromised patients.[7].

Fungal infections, though less common, also represent a significant concern in healthcare environments. These infections often affect immunocompromised patients, particularly those in intensive care or undergoing organ transplantation. Candida infections, particularly Candida albicans, can lead to bloodstream infections, urinary tract infections, and gastrointestinal infections. These infections are commonly seen in patients with prolonged antibiotic use or those receiving central venous catheters. [8].

Proper hand hygiene remains the cornerstone of infection prevention. Healthcare workers must wash their hands thoroughly or use alcohol-based hand sanitizers before and after patient interactions. Additionally, the use of PPE such as gloves, gowns, and masks helps prevent the spread of pathogens. Hospitals must implement antibiotic stewardship programs to ensure antibiotics are prescribed appropriately and only when necessary. This helps reduce the development of antibiotic resistance and the spread of resistant pathogens. Regular cleaning and disinfection of surfaces, medical equipment, and patient areas are critical to minimizing the spread of nosocomial pathogens. Particular attention should be paid to high-touch surfaces and equipment that are frequently used. Healthcare facilities should have robust surveillance systems in place to monitor infection rates and identify outbreaks of nosocomial infections. Early detection and isolation of infected patients can prevent the spread of pathogens to others. [9, 10].

conclusion

Nosocomial pathogens are a persistent and significant threat in healthcare settings, causing a wide range of infections that can lead to patient harm, longer hospital stays, and increased healthcare costs. The most common pathogens include antibiotic-resistant bacteria, viruses, fungi, and parasites, which can be transmitted through contaminated surfaces, invasive medical devices, and inadequate hygiene practices. By implementing effective infection control measures, such as proper hand hygiene, antibiotic stewardship, environmental cleaning, and vaccination, hospitals can reduce the spread of nosocomial infections and protect patients from these preventable threats. Awareness and adherence to best practices in infection control are essential in ensuring a safer healthcare environment for both patients and healthcare workers.

References

  1. Wong F, de la Fuente-Nunez C, Collins JJ. Leveraging artificial intelligence in the fight against infectious diseases. 2023;381(6654):164-70.

    2. Indexed at, Google Scholar, Cross Ref

  2. Nii-Trebi NI. Emerging and neglected infectious diseases: insights, advances, and challenges. Biomed Res Int. 2017;2017(1):5245021.

    3. Indexed at, Google Scholar, Cross Ref

  3. Hao R, Liu Y, Shen W, et al. Surveillance of emerging infectious diseases for biosecurity. Sci China Life Sci. 2022;65(8):1504-16.

    4. Indexed at, Google Scholar, Cross Ref

  4. Le T, Sun C, Chang J, et al. mRNA vaccine development for emerging animal and zoonotic diseases. 2022;14(2):401.

    5. Indexed at, Google Scholar, Cross Ref

  5. Li H, Bai R, Zhao Z, et al. Application of droplet digital PCR to detect the pathogens of infectious diseases. Biosci Rep. 2018;38(6):BSR20181170.

    6. Indexed at, Google Scholar, Cross Ref

  6. Liu CL, Zhou T, Cheng LB, et al. The History of Controlling and Treating Infectious Diseases in Ancient China. Curr Med Sci. 2024;44(1):64-70.

    7. Indexed at, Google Scholar, Cross Ref

  7. Wang X, Chakraborty B. The sequential multiple assignment randomized trial for controlling infectious diseases: a review of recent developments. Am J Public Health 2023;113(1):49-59.

    8. Indexed at, Google Scholar, Cross Ref

  8. Morens DM, Fauci AS. Emerging pandemic diseases: how we got to COVID-19. Cell. 2020;182(5):1077-92.

    9. Indexed at, Google Scholar, Cross Ref

  9. Ellwanger JH, de Lima Kaminski V, Chies JA. Emerging infectious disease prevention: Where should we invest our resources and efforts?. J Infect Public Health. 2019;12(3):313-6.

    10. Indexed at, Google Scholar, Cross Ref          

  10. Mercer A. Protection against severe infectious disease in the past. Pathog Glob Health. 2021;115(3):151-67.

    11. Indexed at, Google Scholar, Cross Ref

Get the App